# REGENXBIO Inc. (RGNX): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for REGENXBIO Inc. (RGNX) is 10/100, ranked against 24,000+ stocks in 35 markets (Quality 23, Value 29, Momentum 31, each scored against its sector).

- StockRank: 10/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 23, Value 29, Momentum 31: each a 0-100 percentile within Healthcare.
- Position: #23,929 overall, #2,309 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 6.58 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 949K; directors sold USD 887K.

Source: https://moatmap.ai/stock/RGNX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker